F390C
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-02824 |
| CAS | |
| Molecular Weight | 318.28 |
| Molecular Formula | C16H14O7 |
Online Inquiry
Description
It is an anti-tumor antibiotic produced by Penicillum sp.AJ 117292.
Specification
| Synonyms | F-390C; F-390-C; methyl (4R,4aS)-4,8-dihydroxy-6-(hydroxymethyl)-9-oxo-4,9-dihydro-4aH-xanthene-4a-carboxylate |
| IUPAC Name | methyl (4R,4aS)-4,8-dihydroxy-6-(hydroxymethyl)-9-oxo-4H-xanthene-4a-carboxylate |
| Canonical SMILES | COC(=O)C12C(C=CC=C1C(=O)C3=C(C=C(C=C3O2)CO)O)O |
| InChI | InChI=1S/C16H14O7/c1-22-15(21)16-9(3-2-4-12(16)19)14(20)13-10(18)5-8(7-17)6-11(13)23-16/h2-6,12,17-19H,7H2,1H3/t12-,16+/m1/s1 |
| InChI Key | PMHCAQUSIVAZPO-WBMJQRKESA-N |
Properties
| Appearance | Yellow Powder |
| Antibiotic Activity Spectrum | neoplastics (Tumor) |
Reference Reading
1. Inhibition of DNA topoisomerases by nidulalin A derivatives
S Sato, Y Fukuda, R Nakagawa, T Tsuji, K Umemura, T Andoh Biol Pharm Bull. 2000 Apr;23(4):511-2. doi: 10.1248/bpb.23.511.
Three cytotoxic dihydroxanthone derivatives, nidulalin A(1), F390B(2), and F390C(3) were evaluated for inhibitory activity against DNA topoisomerases. Compounds 1 and 2 inhibited DNA topoisomerase II with IC50 values of 2.2 microM and 16 microM, and 3 inhibited DNA topoisomerase I with an IC50 value of 5.9 microM.
Recommended Products
| BBF-03827 | Polymyxin B sulphate | Inquiry |
| BBF-03781 | Resveratrol | Inquiry |
| BBF-01851 | Fumagillin | Inquiry |
| BBF-03819 | Spinosyn A | Inquiry |
| BBF-01829 | Deoxynojirimycin | Inquiry |
| BBF-04609 | 1,1-Dimethylbiguanide hydrochloride | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
